摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

per-O-valeryl-β-cyclodextrin | 121783-11-7

中文名称
——
中文别名
——
英文名称
per-O-valeryl-β-cyclodextrin
英文别名
tri-O-valeryl-β-cyclodextrin;[(1R,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradeca(pentanoyloxy)-10,15,20,25,30,35-hexakis(pentanoyloxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methyl pentanoate
per-O-valeryl-β-cyclodextrin化学式
CAS
121783-11-7
化学式
C147H238O56
mdl
——
分子量
2901.47
InChiKey
ABHUFUIOWKJYKZ-SMOFKLLHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    25.8
  • 重原子数:
    203
  • 可旋转键数:
    112
  • 环数:
    21.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    682
  • 氢给体数:
    0
  • 氢受体数:
    56

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    per-O-valeryl-β-cyclodextrin三乙基硅烷三氟甲磺酸三甲基硅酯 作用下, 生成 Pentanoic acid (2R,3R,4S,5S)-3-hydroxy-5-pentanoyloxy-2-pentanoyloxymethyl-tetrahydro-pyran-4-yl ester
    参考文献:
    名称:
    还原裂解法表征环麦芽六糖和庚糖衍生物
    摘要:
    摘要:通过还原裂解方法研究了带有烷基,酰基和氨基甲酰基取代基的环麦芽六糖和庚糖衍生物的取代方式。用三乙基硅烷和三甲基甲硅烷基三氟甲磺酸酯处理改性的环麦芽六糖或庚二酮酶,得到相应的1,5-和1,4-脱水葡萄糖醇衍生物,将其乙酰化,或在乙酰基衍生物的情况下,将三氟乙酰基化,并通过glc-ms分析可以检测到烷基化化合物,烷基化不足或烷基化形成的微量产物或异构体组分。观察到酰氧基部分还原为烷氧基和酰基取代基的裂解。氨基甲酰基取代基在还原裂解的条件下是稳定的。
    DOI:
    10.1016/0008-6215(89)80003-5
  • 作为产物:
    描述:
    戊酸酐β-环糊精 作用下, 反应 24.0h, 以91%的产率得到per-O-valeryl-β-cyclodextrin
    参考文献:
    名称:
    A Simple and Convenient Per-O-acylation of Cyclodextrins Catalyzed by Molecular Iodine
    摘要:
    在无溶剂条件下,通过用羧酸酐对环糊精的所有羟基进行碘催化酰化,以良好至高产率制备了具有不同烷基链的全O-酰化环糊精。
    DOI:
    10.1055/s-0030-1258163
点击查看最新优质反应信息

文献信息

  • Characterization of Peracylated .BETA.-Cyclodextrins with Different Chain Lengths as a Novel Sustained Release Carrier for Water-Soluble Drugs.
    作者:Fumitoshi HIRAYAMA、Masayuki YAMANAKA、Takashi HORIKAWA、Kaneto UEKAMA
    DOI:10.1248/cpb.43.130
    日期:——
    A new series of peracylated β-cyclodextrins (β-CyDs) with different alkyl chains (acetyl-lauroyl) was prepared in high purity by acylating all hydroxyl groups of β-CyD using acid anhydrides in pyridine, and their physicochemical properties of solubility, hydrolsis and release and interaction capacity were evaluated. The solublity of peracylated β-CyDs in water decreased with lengthening alkyl chain, whereas that in ethanol/water increased with increase in ethanol concentration, but tended to decrease at higher ethanol concentration. The solubility parameter of peracylated β-CyDs was determined by analyzing the peak-solubility phenomenon by a modified Hildebrand equation. The alkaline hydrolysis rate of peracylated β-CyDs decreased with lengthening alkyl chain, and was about 4-fold faster than that of the corresponding fatty acid ethyl esters. The interaction of perbutanoyl-β-CyD (TB-β-CyD) with a water-soluble drug, molsidomine, in the solid state was investigated by differential scanning calorimetry (DSC). The analysis of DSC curves suggested that molsidomine and TB-β-CyD form a binary solid dispersion with a 2 : 1 (drug : TB-β-CyD) molar ratio. The rate of drug release was markedly retarded by the combination with peracylated β-CyDs in the increasing order of the hydrophobicity of host molecules.
    一种新的醇酰化β-环糊精(β-CyD)系列,采用不同的烷基链(醋酸-月桂酰基)在高纯度下制备,通过在吡啶中使用酸酐对β-CyD的所有羟基进行酰化,并评估了其在溶解度、水解、释放和相互作用能力方面的物理化学性质。醇酰化β-CyDs在水中的溶解度随着烷基链的延长而降低,而在乙醇/水中的溶解度则随着乙醇浓度的增加而增加,但在较高乙醇浓度下则趋于降低。通过分析峰值溶解现象,采用改进的希尔德布兰德方程确定了醇酰化β-CyDs的溶解度参数。醇酰化β-CyDs的碱性水解速率随着烷基链的延长而降低,且约为相应脂肪酸乙酯的4倍。通过差示扫描量热法(DSC)研究了铂丁酰-β-CyD(TB-β-CyD)与一种水溶性药物莫沙吡啶在固态下的相互作用。DSC曲线的分析表明,莫沙吡啶与TB-β-CyD形成一种2:1(药物:TB-β-CyD)摩尔比的二元固体分散体。药物释放速率因与醇酰化β-CyDs的结合而显著减缓,且减缓程度按宿主分子的疏水性递增排列。
  • Peracylated β-Cyclodextrins as Novel Sustained-release Carriers for a Water-soluble Drug, Molsidomine
    作者:Kaneto Uekama、Takashi Horikawa、Masayuki Yamanaka、Fumitoshi Hirayama
    DOI:10.1111/j.2042-7158.1994.tb03889.x
    日期:2011.4.12
    Abstract

    Peracylated β-cyclodextrins with different alkyl chains (acetyl-octanoyl) were prepared by acylating all hydroxyl groups of β-cyclodextrin (β-CyD), and their physical properties were evaluated. These hydrophobic β-CyDs decreased the release rate of molsidomine, a peripheral vasodilator, in proportion to the lengthening of alkyl chain and suppressed a peak plasma level of molsidomine following oral administration of peracylated β-CyD complexes to dogs. Among the peracylated β-CyDs tested, perbutanoyl-β-CyD maintained sufficient plasma drug levels for a long period of time, while other peracylated β-CyDs having shorter or longer chains were inappropriate to control the in-vivo release behaviour of molsidomine. The prominent retarding effect of perbutanoyl-β-CyD was ascribable to the appropriate mucoadhesive property and hydrophobicity, compared with other peracylated β-CyDs. The present results suggest that perbutanoyl-β-CyD is particularly useful in modifying the release rate of water-soluble drugs as a novel slow-release carrier.

    摘要

    通过酰化β-环糊精(β-CyD)的所有羟基,制备了具有不同烷基链(乙酰-辛酰)的过酰化β-环糊精,并评估了它们的物理性质。这些疏水性β-CyD随着烷基链的延长而降低了周围血管扩张剂莫西多明的释放速率,并通过口服给犬类的过酰化β-CyD复合物抑制了莫西多明的峰值血浆水平。在测试的过酰化β-CyD中,过丁酰-β-CyD维持了足够长时间的血药平衡,而其他烷基链较短或较长的过酰化β-CyD则不适合控制莫西多明的体内释放行为。与其他过酰化β-CyD相比,过丁酰-β-CyD的显著减缓效果可归因于其适当的黏附性和疏水性。本研究结果表明,过丁酰-β-CyD作为一种新型缓释载体,特别适用于调节水溶性药物的释放速率。

  • Characterization of cyclomalto-hexaose and -heptaose derivatives by the reductive-cleavage method
    作者:Petra Mischnick-Lübbecke、Ralph Krebber
    DOI:10.1016/0008-6215(89)80003-5
    日期:1989.4
    The substitution patterns of cyclomalto-hexaose and -heptaose derivatives carrying alkyl, acyl, and carbamoyl substituents have been investigated by the reductive-cleavage method. The modified cyclomalto-hexaoses or -heptaoses were treated with triethylsilane and trimethylsilyl trifluoromethanesulfonate to give the corresponding 1,5- and 1,4-anhydroglucitol derivatives that were acetylated or, in the
    摘要:通过还原裂解方法研究了带有烷基,酰基和氨基甲酰基取代基的环麦芽六糖和庚糖衍生物的取代方式。用三乙基硅烷和三甲基甲硅烷基三氟甲磺酸酯处理改性的环麦芽六糖或庚二酮酶,得到相应的1,5-和1,4-脱水葡萄糖醇衍生物,将其乙酰化,或在乙酰基衍生物的情况下,将三氟乙酰基化,并通过glc-ms分析可以检测到烷基化化合物,烷基化不足或烷基化形成的微量产物或异构体组分。观察到酰氧基部分还原为烷氧基和酰基取代基的裂解。氨基甲酰基取代基在还原裂解的条件下是稳定的。
  • A Simple and Convenient Per-O-acylation of Cyclodextrins Catalyzed by Molecular Iodine
    作者:Tsugio Kitamura、Yasuhiro Ide、Yuji Hori、Soichi Kobayashi、Md. Hossain
    DOI:10.1055/s-0030-1258163
    日期:2010.9
    Per-O-acylated cyclodextrins with different alkyl chains were prepared in good to high yields by iodine-catalyzed acylation of all hydroxy groups of cyclodextrins with carboxylic anhydrides under solvent-free conditions.
    在无溶剂条件下,通过用羧酸酐对环糊精的所有羟基进行碘催化酰化,以良好至高产率制备了具有不同烷基链的全O-酰化环糊精。
查看更多

同类化合物

霉酚酸苯酚beta-D-葡糖苷 阜孢霉素B 阜孢杀菌素 蔗糖棕榈酸酯 蔗糖四异硬脂酸酯 蔗糖七月桂酸酯 药喇叭(IPOMOEAPURGA)树脂 硫脂I 石斛碱;青藤碱 环戊羧酸,1-氨基-2-甲基-,(1R,2S)-rel- 海藻糖 6,6'-二山嵛酸酯 木松香II 木松香I 单岩藻糖基乳糖-N-四糖 二唾液酸乳-N-四糖 乳糖醛酸 乙醋化己二酸双淀粉 中文名称暂缺 β-D-呋喃果糖基-α-D-吡喃葡萄苷二硬脂酸酯 Β-D-呋喃果糖基-Α-D-吡喃葡糖苷十二酸双酯 alpha-D-吡喃葡萄糖基-alpha-D-吡喃葡萄糖苷 6-(3-羟基-2-十四烷基十八烷酸酯) [(3aR,5R,5aR,8aS,8bR)-2,2,7,7-四甲基四氢-3aH-二[1,3]二噁唑并[4,5-b:4',5'-d]吡喃-5-基]甲基丁酸酯(non-preferredname) [(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6R)-6-(十六烷酰氧基甲基)-3,4,5-三羟基四氢吡喃-2-基]氧基-3,4,5-三羟基四氢吡喃-2-基]甲基十六烷酸酯 [(2R,3S,4S,5R)-3,4-二羟基-2,5-二(羟基甲基)四氢呋喃-2-基][(2R,3S,4S,5R,6S)-3,4,5,6-四羟基四氢吡喃-2-基]甲基2-甲基-4-(2-甲基癸-1-烯-4-基)己二酸酯 [(2R,3R,4S,5R,6R)-6-[[(1R,2R,3R,4R,6R)-2,3-二羟基-5,8-二氧杂双环[4.2.0]辛烷-4-基]氧基]-3,4,5-三羟基四氢吡喃-2-基]甲基3-羟基-2-十四烷基十八烷酸酯 N-乙酰基-硫代胞壁酰-丙氨酰-异谷氨酰胺 N-(O-alpha-D-甘露糖基-(1-3)-O-(O-alpha-D-甘露糖基-(1->3)-O-(alpha-D-甘露糖基-(1-6))-alpha-D-甘露糖基-(1-6))-O-beta-D-甘露糖基-(1->4)-O-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基-(1->4)-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基)-L-天冬氨酰胺 L-缬氨酰-L-丙氨酰-L-缬氨酰甘氨酰-L-α-谷氨酰-L-α-谷氨酰-L-脯氨酰甘氨酰-L-脯氨酰-N~5~-(二氨基甲亚基)-L-鸟氨酸酰胺 D-甘露糖基-(1-6)-D-甘露糖基-(1-4)-2-乙酰氨基-2-脱氧-D-吡喃葡萄糖基-(1-4)-2-乙酰氨基-1-N-(4'-L-天冬氨酰)-2-脱氧-beta-D-吡喃葡萄糖基胺 D-(+)-海藻糖6-单油酸酯 9,10-二氯-2,6-二甲基蒽 8-甲氧基羰基辛基2-O-(aL-呋喃基呋喃糖基)-3-O-(aD-吡喃半乳糖基)-bD-吡喃半乳糖苷 6-山慈菇甙A 6-O-alpha-D-吡喃半乳糖基-D-葡萄糖酸 6,6'-二((2R,3R)-3-羟基-2-十四烷基十八烷酸酯)-海藻糖 4H-吡咯并[3,2,1-脱]蝶啶,5,6-二氢-4,5-二甲基-(9CI) 4-嘧啶甲腈,2-苯基- 4-[[(2R)-2-羟基-3,3-二甲基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基丁酰基]氨基]丁酸 4-[6-(1,2-二羟基乙基)-3,4,5-三羟基-四氢吡喃-2-基]氧基-2,3,5-三羟基-7,8-二氧代-辛酸 3-O-棕榈酰-beta-D-呋喃果糖基2,3-二-O-棕榈酰-alpha-D-吡喃葡萄糖苷 3-(6H-苯并[b][1,5]苯并噁噻庚英-6-基)丙基-二甲基-铵2-羟基-2-羰基-乙酸酯 2-脱氧-3-O-[(3R)-3-羟基十四烷酰基]-2-{[(3R)-3-羟基十四烷酰基]氨基}-1-O-膦酰-alpha-D-吡喃葡萄糖 2-氨基-6-[[3,5,6-三羟基-2-氧代-4-[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基己基]氨基]己酸 2-氨基-4-氧代-4-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氨基]丁酸 2-N-(羧基丙基氨基)-2-脱氧葡萄吡喃糖 2,6-二甲基-6-(3-O-(beta-吡喃葡萄糖基)-4-O-(2-甲基丁酰基)alpha-阿拉伯吡喃糖基氧基)-2,7-辛二烯酸 1-二甲胺基萘-5-磺酰-甘氨酰-赖氨酰-酪氨酰-丙氨酰-脯氨酰-色氨酰-缬氨酸 1-O,2-O,3-O-三(3-硝基丙酰基)-alpha-D-吡喃葡萄糖 1,1-O-(4,6-二羟基-1,2-亚苯亚甲基)-4-O-[6-O-(1-氧代-2,4-癸二烯基)-beta-D-吡喃半乳糖基]-alpha-D-吡喃葡萄糖3-(7-羟基-8,14-二甲基十六碳-2,4,8,10-四烯酸酯) (Z,Z)-甲基-D-吡喃葡糖苷-2,6-二油酸酯